In the current study, we evaluated Imaging and genomic data for patients with Microsatellite instability high (MSI-H) metastatic colorectal carcinoma (mCRC) to determine whether Radiomics Based on MRI could be used to select the patients with MSI-H status. Using the pretreatment MRI data, we developed a radiomics model with excellent performance for individualized, noninvasive prediction of MSI-H in patients with mCRC and potentially guide treatment.
This abstract and the presentation materials are available to members only; a login is required.